Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search Stock, IPO, MF
Open in App
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
Charts & Report
Charts and Graphs
Stock Report Pdf
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Divi's Laboratories Ltd.
NSE: DIVISLAB
|
BSE: 532488
|
ISIN: INE361B01024
|
Industry: Pharmaceuticals
|
Expensive Star
9357.0000
-81.50
(
-0.86
%)
NSE
Sep 11, 2026
11:32 AM
New 52W High in past week
Volume:
234.7K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Divi's Laboratories Ltd.
25 Mar 2025
9357.00
-0.86%
DIVI' S LAB
Hold:
Divi's Laboratories Ltd.
by
Geojit BNP Paribas
Target: 6375
Target
Geojit BNP Paribas
Number of FII/FPI investors increased from 842 to 864 in Jun 2026 qtr.
More from Divi's Laboratories Ltd.
Recommended
Market trades lower, Granules' promoter to sell a Rs 1,500 crore stake
Trendlyne Marketwatch |
11 Sep 2026, 11:30AM
Multibaggers are starting to make a comeback. But we should not get too excited
The Baseline |
10 Sep 2026, 01:28PM
Custom synthesis business drives growth for Divi’s Laboratories
|
10 Mar 2022, 06:14AM